CNS Gene Therapy

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Neurosciences
  • Medical Biotechnology


In the gene therapy group our main interest is to develop systems for sufficient and sustained expression of transgenes in the CNS. We are using gene transfer to express trophic factors or neurotransmitter-producing enzymes in animal models of neurodegenerative disease. We are currently working with three different vector systems: adeno-associated viral, retroviral and lentiviral. These vectors can be used both for direct injection (in vivo gene transfer) or transduction of cells in culture for subsequent transplantation (ex vivo gene transfer). To address the problem of sustained expression in vivo (a major limitation of many gene transfer methods as of now) we are investigating the use of different promoters, post-transcriptional regulating elements and vectors.

Recent research outputs

Marcus Lockowandt, Dorothee M. Günther, Luis Quintino, Ludvine S. Breger, Christina Isaksson & Cecilia Lundberg, 2020 Apr 15, In: Journal of Neuroscience Methods. 336, 108542.

Research output: Contribution to journalArticle

Marcus Davidsson, Matilde Negrini, Swantje Hauser, Alexander Svanbergsson, Marcus Lockowandt, Giuseppe Tomasello, Fredric P. Manfredsson & Andreas Heuer, 2020, In: Scientific Reports. 10, 1, 21532.

Research output: Contribution to journalArticle

Valentina Di Maria, Marine Moindrot, Martin Ryde, Antonino Bono, Luis Quintino & Marco Ledri, 2020, In: Frontiers in Molecular Neuroscience. 13, 168.

Research output: Contribution to journalArticle

View All (69)